| Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection JFS Mann, E Shakir, KC Carter, AB Mullen, J Alexander, VA Ferro Vaccine 27 (27), 3643-3649, 2009 | 190 | 2009 |
| Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude X Qu, VV Khutoryanskiy, A Stewart, S Rahman, ... Biomacromolecules 7 (12), 3452-3459, 2006 | 181 | 2006 |
| Both interleukin-4 (IL-4) and IL-4 receptor α signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity S Stager, J Alexander, KC Carter, F Brombacher, PM Kaye Infection and immunity 71 (8), 4804-4807, 2003 | 169 | 2003 |
| Neutrophils Contribute to Development of a Protective Immune Response during Onset of Infection with Leishmania donovani E McFarlane, C Perez, M Charmoy, C Allenbach, KC Carter, J Alexander, ... Infection and immunity 76 (2), 532-541, 2008 | 163 | 2008 |
| Endogenous IL‐4 is necessary for effective drug therapy against visceral leishmaniasis J Alexander, KC Carter, N Al‐Fasi, A Satoskar, F Brombacher European journal of immunology 30 (10), 2935-2943, 2000 | 163 | 2000 |
| Toll‐like receptor‐4‐mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors LA Jones, JP Anthony, FL Henriquez, RE Lyons, MB Nickdel, KC Carter, ... Immunology 125 (1), 59-69, 2008 | 134 | 2008 |
| Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis AB Mullen, KC Carter, AJ Baillie Antimicrobial agents and chemotherapy 41 (10), 2089-2092, 1997 | 113 | 1997 |
| The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent KC Carter, AJ Baillie, J Alexander, TF Dolan Journal of pharmacy and pharmacology 40 (5), 370-373, 1988 | 101 | 1988 |
| Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity JFS Mann, HE Scales, E Shakir, J Alexander, KC Carter, AB Mullen, ... Methods 38 (2), 90-95, 2006 | 100 | 2006 |
| Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin JFS Mann, VA Ferro, AB Mullen, L Tetley, M Mullen, KC Carter, ... Vaccine 22 (19), 2425-2429, 2004 | 89 | 2004 |
| The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin 4 treatment KC Carter, G Gallagher, AJ Baillie, J Alexander European journal of immunology 19 (4), 779-782, 1989 | 84 | 1989 |
| An essential role for IL‐13 in maintaining a non‐healing response following Leishmania mexicana infection J Alexander, F Brombacher, HA McGachy, ANJ McKenzie, W Walker, ... European journal of immunology 32 (10), 2923-2933, 2002 | 79 | 2002 |
| Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected BALB/c mice KC Carter, TF Dolan, J Alexander, AJ Baillie, C McColgan Journal of Pharmacy and Pharmacology 41 (2), 87-91, 1989 | 79 | 1989 |
| In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization CD Shaw, J Lonchamp, T Downing, H Imamura, TM Freeman, JA Cotton, ... Molecular microbiology 99 (6), 1134-1148, 2016 | 78 | 2016 |
| The In Vivo Susceptibility of Leishmania donovani to Sodium Stibogluconate Is Drug Specific and Can Be Reversed by Inhibiting Glutathione Biosynthesis KC Carter, S Sundar, C Spickett, OC Pereira, AB Mullen Antimicrobial agents and chemotherapy 47 (5), 1529-1535, 2003 | 77 | 2003 |
| Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™ JL Italia, A Sharp, KC Carter, P Warn, MNVR Kumar PloS one 6 (10), e25744, 2011 | 74 | 2011 |
| Resistance of Leishmania donovani to Sodium Stibogluconate Is Related to the Expression of Host and Parasite γ-Glutamylcysteine Synthetase KC Carter, S Hutchison, FL Henriquez, D Legare, M Ouellette, ... Antimicrobial agents and chemotherapy 50 (1), 88-95, 2006 | 74 | 2006 |
| Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™ JL Italia, A Sharp, KC Carter, P Warn, MNVR Kumar PloS one 6 (10), e25744, 2011 | 73 | 2011 |
| The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection M Alsaadi, JL Italia, AB Mullen, MNVR Kumar, AA Candlish, ... Journal of controlled release 160 (3), 685-691, 2012 | 66 | 2012 |
| Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals J Nieto, J Alvar, AB Mullen, KC Carter, C Rodríguez, MI San Andrés, ... Antimicrobial agents and chemotherapy 47 (9), 2781-2787, 2003 | 66 | 2003 |
